[go: up one dir, main page]

DE27882T1 - Optical cephalosporin analogs, processes for their preparation, pharmaceutical compositions containing them and their use - Google Patents

Optical cephalosporin analogs, processes for their preparation, pharmaceutical compositions containing them and their use

Info

Publication number
DE27882T1
DE27882T1 DE1980105493 DE80105493T DE27882T1 DE 27882 T1 DE27882 T1 DE 27882T1 DE 1980105493 DE1980105493 DE 1980105493 DE 80105493 T DE80105493 T DE 80105493T DE 27882 T1 DE27882 T1 DE 27882T1
Authority
DE
Germany
Prior art keywords
enzyme
group
hydrogen atom
compounds
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1980105493
Other languages
German (de)
Inventor
Tadashi Yokohama Kanagawa; Ogasa Takehiro; Kobayashi Shigeru; Machida Tokio; Sato Kiyoshi Shizuoka; Sato Akira Machida Tokio; Hashimoto Yukio Yamato; Takasawa Seigo Hadano; Kanagawa; Suzuki Fumio Machida Tokio; JP Hirata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE27882T1 publication Critical patent/DE27882T1/en
Pending legal-status Critical Current

Links

Claims (1)

Patentansprüche (Übersetzung nach Art. 67 EPÜ) Claims (translation under Art. 67 EPC) Optisch aktive Cephalosporin-Analoga der allgemeinen Formel IOptically active cephalosporin analogs of the general formula I COOR,COOR, (I)(I) in der R1 ein Wasserstoffatom, einen niederen Alkylrest oder eine niedere Acylgruppe bedeutet und R- ein Wasserstoffatom oder eine Carbonsäureschutzgruppe darstellt, sowie Ihre Salze.in which R 1 denotes a hydrogen atom, a lower alkyl radical or a lower acyl group and R- denotes a hydrogen atom or a carboxylic acid protective group, as well as their salts. Verbindungen nach Anspruch 1, in denen stoff atom ist.Compounds according to claim 1, in which substance is atom. ein Wassera water Verbindungen nach Anspruch 2, in der R„ ein Wasserstoff atom bedeutet, nämlich (6R, 7S)-7-Amino-4-hydroxy-1-azabicyclo[4.2.0]oct-2-en-8-on-2-carbonsäure. Compounds according to claim 2, in which R "is hydrogen atom means, namely (6R, 7S) -7-amino-4-hydroxy-1-azabicyclo [4.2.0] oct-2-en-8-one-2-carboxylic acid. Verbindung nach Anspruch 3, in der die Konfiguration in der 4-Stellung "S" ist, nämlich (4S, 6R, 7S)-7-Amino-4-hydroxy-1-azabicyclo[4.2.0]oct-2-en-8-on-2-carbonsäure. A compound according to claim 3 in which the configuration in the 4-position is "S", namely (4S, 6R, 7S) -7-amino-4-hydroxy-1-azabicyclo [4.2.0] oct-2-en-8-one-2-carboxylic acid. 13O717/O0T113O717 / O0T1 Verfahren zur Herstellung optisch aktiver Verbindungen der allgemeinen Formel IProcess for the preparation of optically active compounds of the general formula I. (D(D COOR,COOR, in der R1 ein Wasserstoffatom, einen niederen Alkylrest oder eine niedere Acylgruppe bedeutet, und R2 ein ffasserstoffatom oder eine Carbonsäureschutzgruppe darstellt, dadurch gekennzeichnet, daß man eine Verbindung der allgemeinen Formel Vin which R 1 is a hydrogen atom, a lower alkyl radical or a lower acyl group, and R 2 is a constituent atom or a carboxylic acid protective group, characterized in that a compound of the general formula V H R-CHCONH R-CHCON COOR,COOR, (V)(V) in der R einen substituierten oder unsubstxtuierten ungesättigten 6-gliedrigen Carbocyclus, eine Phenoxygruppe oder einen substituierten oder unsubstituierten Heterocyclus darstellt, X ein Wasserstoffatom, eine Aminogruppe, Hydroxylgruppe oder eine niedere Alkylgruppe darstellt, R1 und R2 die vorstehende Bedeutung haben und die Wasserstoffatome in den 6- und 7-Stellungen die cis-Konfiguration haben,in which R represents a substituted or unsubstituted unsaturated 6-membered carbocycle, a phenoxy group or a substituted or unsubstituted heterocycle, X represents a hydrogen atom, an amino group, hydroxyl group or a lower alkyl group, R 1 and R 2 have the above meaning and the hydrogen atoms in the 6 and 7 positions have the cis configuration, mit einem Enzym zur Umsetzung bringt, das zur selektiven optischen Deacylierung befähigt ist, und man anschließend die optisch aktiven Verbindungen isoliert.brings with an enzyme to implement, which is capable of selective optical deacylation, and then one isolates the optically active compounds. 13 0717/001113 0717/0011 6. Verfahren nach Anspruch 5, dadurch gekennzeichnet, daß man ein aus einem Mikroorganismus der Gattung6. The method according to claim 5, characterized in that one from a microorganism of the genus Arthrobacter,/ Aeromonas, Achromobacter,/ ACetöbacter, Alcaligenes, Escherichia, Xanthomonas, Kluyvera, Gluconobacter, Clostridium, Comamonas, Corynebacterium, Sarcina, Staphylococcus, Streptomyces, Spirillum, Bacillus, Pseudomonas, Flavobacterium, Brevibacterium, Protaminobacter, Proteus, Beneckea, Micrococcus, : Mycoplana, Rhodopseudomonas, Nocardia, Neurospora, Talaromyces oder Acinetobacter hergestelltes Enzym einsetzt.Ar throbacter, / Aeromonas, Achromobacter, / ACetöbacter, Alcaligenes, Escherichia, Xanthomonas, Kluyvera, Gluconobacter, Clostridium, Comamonas, Corynebacterium, Sarcina, Staphylococcus, Streptomyces, Spirillum, Bacillus, Pseudomonas, Protaminobacterium, Bacterium, Brevobacterium, Brevibacterium, Brevobacterium, Brevibacterium ,: Mycoplana, Rhodopseudomonas, Nocardia, Neurospora, Talaromyces or Acinetobacter used enzyme. 7. Verfahren nach Anspruch 6, dadurch gekennzeichnet, daß man das genannte Enzym für die genannte Reaktion in Form einer gereinigten Enzymlösung, aus einer Kulturbrühe isolierten Zellkörpern, einer Zellsuspension, einer unterbrochenen Zellsuspension, einem zellfreien Extrakt oder einer Kulturflüssigkeit des Mikroorganismus einsetzt.7. The method according to claim 6, characterized in that said enzyme is used for said reaction in the form of a purified enzyme solution, cell bodies isolated from a culture broth, a cell suspension, an interrupted cell suspension, a cell-free extract or a culture liquid of the microorganism begins. 8. Verfahren nach Anspruch 7, dadurch gekennzeichnet, daß man als Enzym ein immobilisiertes Enzym einsetzt.8. The method according to claim 7, characterized in that an immobilized enzyme is used as the enzyme. 9. Pharmazeutische Zubereitungen mit antimikrobieller Wirksamkeit, gekennzeichnet durch einen Gehalt einer Verbindung gemäß jedem der Ansprüche 1 bis 4.9. Pharmaceutical preparations with antimicrobial effectiveness, characterized by a content of a A compound according to any one of claims 1 to 4. 10. Verwendung der Verbindungen gemäß jedem der Ansprüche bis 4 als Ausgangsverbindungen zur Herstellung von Verbindungen mit antimikrobieller Wirksamkeit.10. Use of the compounds according to any one of claims to 4 as starting compounds for the preparation of Compounds with antimicrobial activity. 130717/0011130717/0011
DE1980105493 1979-10-25 1980-09-12 Optical cephalosporin analogs, processes for their preparation, pharmaceutical compositions containing them and their use Pending DE27882T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13698679 1979-10-25
JP5561880 1980-04-26
JP10242280 1980-07-28

Publications (1)

Publication Number Publication Date
DE27882T1 true DE27882T1 (en) 1982-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
ATE72835T1 (en) PROCESS FOR THE PRODUCTION OF HIGH MOLECULAR SODIUM HYALURONATE BY FERMENTATION OF STREPTOCOCCUS.
DE2343587A1 (en) PROCESS FOR THE PRODUCTION OF 2-KETOL-GULONIC ACID
ES8204762A1 (en) Method for preparing 2,5-diketo-D-gluconic acid and microorganisms for carrying out the method.
DE2631048B2 (en) Process for the preparation of D-phenylglycine
DE3127979C2 (en) Use of a specific cholesterase to hydrolyze cholesterol fatty acid esters
DE2757980C2 (en)
GB1157213A (en) Process for the Manufacture of D-Lactic Acid and its Salts
DE27882T1 (en) Optical cephalosporin analogs, processes for their preparation, pharmaceutical compositions containing them and their use
JPS5878594A (en) Preparation of antibiotic substance b-41d, e, and g
DE1967074C3 (en) Process for the preparation of α-aminobenzylpenicillin
EP0346467A1 (en) Process for purifying hyaluronic acid
Yentsch et al. Stimulatory Effects on Growth and Photosynthesis of the Toxic Red Tide Dinoflagellate, Gonyaulax Tamarensis, with the Addition of Nitrilotriacetic Acid (NTA) N (CH2COOH) 3
US3414477A (en) Biosynthesis of protein from hydrocarbons using an antibiotic
IE41079B1 (en) Antibiotic a-28086 and process for production thereof
JPS5537136A (en) Preparation of cephalosporin antibiotic
SU1193167A1 (en) Method of differential vibro-type bacteria from aeromonas-type bacteria
DE2152548B2 (en) PROCESS FOR THE PREPARATION OF L-HYDROXYPHENYLALANIA
DE2005848C (en) Extraction of citric acid and isocitric acid
KR880002536A (en) Oxirane pseudooligosaccharide, preparation method thereof and use thereof and pharmaceutical preparation
DE1670033A1 (en) Process for the production of semi-synthetic penicillins by enzymatic means
DE2212276C3 (en) Process for the preparation of 7-aminodeacetoxy-cephalospora acid
DE3170801D1 (en) Amidines, process for their production, pharmaceutical preparations containing them and their use
DE14475T1 (en)
AU2364988A (en) A method for inhibiting the growth of microorganisms
GB1415615A (en) Preparation of 6-aminopenicillanic acid